KEMPHARM, INC·4

Jun 14, 4:37 PM ET

Mickle Travis C 4

4 · KEMPHARM, INC · Filed Jun 14, 2021

Insider Transaction Report

Form 4
Period: 2021-06-14
Mickle Travis C
DirectorPresident & CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2021-06-14$14.43/sh+1,500$21,645119,507 total
Holdings
  • Common Stock

    (indirect: By LLC)
    1,034
  • Common Stock

    (indirect: By Trust)
    7,701
  • Common Stock

    6,287
  • Common Stock

    (indirect: By Trust)
    9,824
  • Common Stock

    (indirect: By Trust)
    15,242
  • Common Stock

    (indirect: By Trust)
    1,341
Footnotes (2)
  • [F1]Held jointly with Christal M.M. Mickle.
  • [F2]The Reporting Person and Christal M.M. Mickle are the managing members of Mickle Investments, LLC.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4